Christina Applegate recently shared surprising news about her health. The actress, known for her roles in popular TV shows, revealed that she was misdiagnosed with multiple sclerosis (MS). This revelation has sparked discussions about how MS can be mistaken for other medical issues, even after a patient has been receiving treatment for years.
During an episode of her podcast, “MeSsy,” aired on October 20, Applegate explained her shock at learning her initial diagnosis was incorrect. The 54-year-old actress had first been diagnosed with MS in 2021 after suffering from severe symptoms and undergoing various medical tests. These tests included MRIs of her brain and spine, which showed numerous lesions.
After several years of treatment, her doctor decided to pause her infusions and observe her B cells instead. “My B cells didn’t change at all,” Applegate explained, and this unexpected finding led her doctor to reconsider her diagnosis. Eventually, after further brain scans, Applegate received the surprising news that she did not have MS. However, she did not view this news as good, expressing her struggles with ongoing symptoms that have even worsened in some aspects.
Applegate stated, “I have every symptom of MS.” She pointed out that numerous other conditions can mimic MS symptoms, underscoring the complexities of diagnosing the illness accurately.
Dr. Marwa Kaisey, a neurologist at Cedars-Sinai in Los Angeles, commented in a subsequent podcast that misdiagnosis of MS is not uncommon. In a study from UCLA and Cedars-Sinai, it was found that nearly 20% of people diagnosed with MS did not actually have the disease, some of whom had been living with this diagnosis for decades.
The challenge with diagnosing MS lies in the lack of a definitive single test that confirms the disease. Dr. Kaisey explained, “It’s not like a pregnancy test that can give a clear answer.” Instead, neurologists depend on a set of criteria, which can sometimes be subjective.
Despite many misdiagnosed patients showing lesions in their MRIs, the source of these lesions might differ from MS. New imaging techniques are being developed to help doctors better differentiate between MS lesions and those caused by other conditions. One of these new findings, known as the “central vein sign,” has shown promise in helping doctors distinguish MS from other abnormalities.
As Dr. Ransohoff, a neurologist from Boston, noted, there are many other conditions that can show similar patterns and mimic MS. Migraines are frequently cited as a common alternative diagnosis, as they can also cause MRI abnormalities.
Dr. Kaisey stressed the importance of patients feeling empowered to seek second opinions if something does not feel right. “Don’t be afraid to ask questions,” she advised.
Moving forward, specialists play a vital role in reducing misdiagnosis rates. Dr. Ransohoff recommends that anyone diagnosed with MS visit a specialist who has extensive experience with the disease and its treatment options. Advances in treatment have transformed the outlook for those correctly diagnosed, leading to improved health and quality of life for many.
In conclusion, while the uncertainty surrounding Applegate’s diagnosis has been difficult, it highlights the importance of thorough evaluation and the need for ongoing communication between patients and their doctors. As research continues to evolve, understanding and diagnosing MS will hopefully become more precise, offering hope for better outcomes for everyone affected.
